PBMs Agree to Display TrumpRx Drug Prices; Bristol's Zenbexus Wins Accelerated Approval

Source Summary

Pharmacy benefit managers have agreed to display TrumpRx drug prices. Bristol Myers Squibb's Zenbexus has received accelerated approval. Novartis won a UK patent dispute over Entresto. Additional biotech developments are reported.